id	domain	url
dhrp-39	doi.org	https://doi.org/10.47488/dhrp.v1is5.39
dhrp-39	dhrproceedings.org	http://dhrproceedings.org
dhrp-39	orcid.org	https://orcid.org/0000-0001-5027-9992
dhrp-39	orcid.org	https://orcid.org/0000-0003-4146-3282
dhrp-39	orcid.org	https://orcid.org/0000-0001-5027-9992
dhrp-39	orcid.org	https://orcid.org/0000-0003-4146-3282
dhrp-39	dhrproceedings.org	http://dhrproceedings.org
dhrp-39	www.cdc.gov	https://www.cdc.gov/coronavirus/2019-ncov/hcp/mitigating-staffshortages.html
dhrp-39	www.cdc.gov	https://www.cdc.gov/coronavirus/2019-ncov/hcp/mitigating-staff-shortages.html
dhrp-39	www.cdc.gov	https://www.cdc.gov/coronavirus/2019-ncov/hcp/mitigating-staff-shortages.html
dhrp-39	dhrproceedings.org	http://dhrproceedings.org
dhrp-39	www.cdc.gov	https://www.cdc.gov/coronavirus/2019ncov/hcp/mitigating-staff-shortages.html
dhrp-39	www.cdc.gov	https://www.cdc.gov/vaccines/covid19/clinical-considerations/covid-19-vaccines-us.html
dhrp-39	www.cdc.gov	https://www.cdc.gov/coronavirus/2019ncov/hcp/guidance-risk-assesment-hcp.html
dhrp-39	www.federalregister.gov	https://www.federalregister.gov/documents/2021/11/05
dhrp-39	www.fda.gov	https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fdaauthorizes-new-long-acting-monoclonal-antibodies-preexposure
dhrp-39	www.fda.gov	www.fda.gov/media/154701/download
dhrp-39	www.almonitor.com	https://www.almonitor.com/originals/2021/12/israel-offer-fourth-covid19-booster-dose
dhrp-39	journals.lww.com	https://journals.lww.com/jaapa/abstract/2020/07000/the_effect_of_the_covid_19_pandemic_on_healthcare.9.aspx
dhrp-39	onlinelibrary.wiley.com	https://onlinelibrary.wiley.com/doi/10.1111/inr.12598
dhrp-39	onlinelibrary.wiley.com	https://onlinelibrary.wiley.com/doi/10.1111/inr.12598
dhrp-39	www.tandfonline.com	https://www.tandfonline.com/doi/full/10.1080/13561820.2020.1792425
dhrp-39	www.tandfonline.com	https://www.tandfonline.com/doi/full/10.1080/13561820.2020.1792425
dhrp-39	www.cdc.gov	https://www.cdc.gov/coronavirus/2019-ncov/hcp/mitigating-staff-shortages.html
dhrp-39	www.cdc.gov	https://www.cdc.gov/coronavirus/2019-ncov/hcp/mitigating-staff-shortages.html
dhrp-39	www.cdc.gov	https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html
dhrp-39	www.cdc.gov	https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html
dhrp-39	www.cdc.gov	https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html
dhrp-39	www.cdc.gov	https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html
dhrp-39	www.federalregister.gov	https://www.federalregister.gov/documents/2021/11/05/2021-23831/medicare-and-medicaid-programs-omnibus-covid-19-health-care-staff-vaccination
dhrp-39	www.federalregister.gov	https://www.federalregister.gov/documents/2021/11/05/2021-23831/medicare-and-medicaid-programs-omnibus-covid-19-health-care-staff-vaccination
dhrp-39	www.federalregister.gov	https://www.federalregister.gov/documents/2021/11/05/2021-23831/medicare-and-medicaid-programs-omnibus-covid-19-health-care-staff-vaccination
dhrp-39	www.fda.gov	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure
dhrp-39	www.fda.gov	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure
dhrp-39	www.fda.gov	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure
dhrp-39	www.fda.gov	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure
dhrp-39	www.fda.gov	https://www.fda.gov/media/154701/download
dhrp-39	www.al-monitor.com	https://www.al-monitor.com/originals/2021/12/israel-offer-fourth-covid-19-booster-dose
dhrp-39	www.al-monitor.com	https://www.al-monitor.com/originals/2021/12/israel-offer-fourth-covid-19-booster-dose
dhrp-39	www.al-monitor.com	https://www.al-monitor.com/originals/2021/12/israel-offer-fourth-covid-19-booster-dose